rs145239537

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001277115.2(DNAH11):​c.7765G>A​(p.Val2589Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,605,864 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 1 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 2.37

Publications

4 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006401092).
BP6
Variant 7-21738820-G-A is Benign according to our data. Variant chr7-21738820-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 257931.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00197 (300/152102) while in subpopulation AFR AF = 0.00682 (283/41466). AF 95% confidence interval is 0.00617. There are 2 homozygotes in GnomAd4. There are 138 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.7765G>A p.Val2589Ile missense_variant Exon 47 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.7765G>A p.Val2589Ile missense_variant Exon 47 of 82 5 NM_001277115.2 ENSP00000475939.1
DNAH11ENST00000605912.1 linkc.325G>A p.Val109Ile missense_variant Exon 2 of 4 3 ENSP00000476068.1

Frequencies

GnomAD3 genomes
AF:
0.00197
AC:
300
AN:
151984
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00685
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000557
AC:
132
AN:
237088
AF XY:
0.000453
show subpopulations
Gnomad AFR exome
AF:
0.00758
Gnomad AMR exome
AF:
0.000359
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000114
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000468
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000261
AC:
380
AN:
1453762
Hom.:
1
Cov.:
30
AF XY:
0.000230
AC XY:
166
AN XY:
722180
show subpopulations
African (AFR)
AF:
0.00861
AC:
287
AN:
33330
American (AMR)
AF:
0.000477
AC:
21
AN:
44034
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25940
East Asian (EAS)
AF:
0.000228
AC:
9
AN:
39526
South Asian (SAS)
AF:
0.0000832
AC:
7
AN:
84088
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52916
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000226
AC:
25
AN:
1108030
Other (OTH)
AF:
0.000466
AC:
28
AN:
60140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00197
AC:
300
AN:
152102
Hom.:
2
Cov.:
32
AF XY:
0.00186
AC XY:
138
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00682
AC:
283
AN:
41466
American (AMR)
AF:
0.000524
AC:
8
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68014
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000757
Hom.:
2
Bravo
AF:
0.00269
ESP6500AA
AF:
0.00689
AC:
30
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000619
AC:
75

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1Benign:2
Dec 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 12, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:1
Mar 29, 2016
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
.;.;T;.
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.58
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.87
D;D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.0064
T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
2.4
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.93
.;N;.;.
REVEL
Benign
0.066
Sift
Uncertain
0.018
.;D;.;.
Sift4G
Uncertain
0.044
.;.;.;D
Vest4
0.12
MVP
0.31
ClinPred
0.021
T
GERP RS
3.6
Varity_R
0.096
gMVP
0.20
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145239537; hg19: chr7-21778438; COSMIC: COSV100180937; API